Brief: BioGaia Q4 Sales, EBIT Miss Consensus Expectations
Feb 3 (Reuters) - BioGaia Q4 adjusted EPS SEK 1.38. * Q4 EBIT margin 26% * Q4 EBIT SEK 71.1 million vs. estimate SEK 79 million * Q4 net income SEK 139.2 million * Q4 sales SEK 274.3 million vs. estimate SEK 290 million